Tag: Asia
-
Liquid Biopsy Lab to Reside at Cancer Institute
A designer of liquid biopsy tests to diagnose cancer is establishing a lab to study circulating tumor cells at John Wayne Cancer Institute in Santa Monica, California.
-
Teva Licenses Pain Relief Antibody for $1.25 Billion
Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals.
-
Takeda Awarded $19.8 Million for Zika Vaccine
Takeda Pharmaceutical Company is receiving $19.8 million from a U.S. public health agency for initial steps to develop a vaccine to prevent Zika infections.
-
$1 Million Challenge Seeks Child Health Solutions
A new challenge seeks technologies and solutions to reduce child mortality and improve the health of children in low-resource regions of the world.
-
Trial Shows Fertility Treatment Boosts IVF Pregnancy Rate
11 August 2015. A clinical study of cellular treatments for women using in-vitro fertilization shows the treatments increased pregnancy rates compared to women receiving standard IVF alone. Findings from the study that tested treatments developed by IVF technology company OvaScience Inc. in Cambridge, Massachusetts are scheduled to be published on 25 August in the Journal…
-
Commercial Space Launch Site Slated for New Zealand
2 July 2015. Rocket Lab Ltd, a company aiming to make orbital space launches frequent and less costly, says it plans to build a launch site in New Zealand, with completion scheduled by the end of 2015. The company says test flights will begin soon after completing construction of the site, with commercial operations planned…
-
Patent Awarded for Early, Pre-Symptom Cancer Tests
16 June 2015. Three researchers at Kansas State University in Manhattan received a patent for an early-stage test that the inventors say can diagnose some solid tumor cancers well before symptoms develop. Kansas State chemistry professor Stefan Bossmann and anatomy-physiology professor Deryl Troyer, with postdoctoral fellow Matthew Basel, received U.S. patent number 8,969,027 in March…
-
Trial Underway Testing Immunotherapy for Gout
10 June 2015. An early-stage clinical trial is recruiting patients to test the safety of a treatment for severe gout that harnesses the immune system, but still avoids unwanted immune responses. The trial is conducted by the biotechnology company Selecta Biosciences at two sites in the U.S.: Altoona, Pennsylvania and Dallas, Texas. Gout is a…
-
Spin-Off Biotech Formed for Autoimmune Disorders
2 June 2015. Drug maker Astellas Pharma Inc. in Tokyo and Anokion SA, a biotechnology company in Lausanne, Switzerland, are forming Kanyos Bio Inc., a spin-off enterprise to develop therapy candidates for autoimmune diseases. The deal could bring Kanyos Bio, based in Cambridge, Massachusetts, as much as $760 million, as well as an equity investment…
-
Astellas Getting First Access to Leukemia Antibody
3 April 2015. MD Anderson Cancer Center in Houston is granting Astellas Pharma Inc. in Tokyo an option to license MD Anderson’s discovery of a synthetic antibody showing promise as a treatment for acute myeloid leukemia. For the licensing option, MD Anderson could earn up to $26 million in fees and research funding. Acute myeloid…